| Product Name | MF | CAS | Details |
|---|
| ethyl 6-methylbenzo[d]thiazole-2-carboxylate | Details |
| 2-(2-bromoethoxy)ethanol | C4H9BrO2 | 57641-66-4 | Details |
| 6-Methylheptanal | C8H16O | 63885-09-6 | Details |
| Drafloxacin Impurity 13 | C36H24Cl2F6N8O8 | 1093185-35-3 | Details |
| Delafloxacin Impurity 3 | C17H12ClF3N4O2 | 2097714-12-8 | Details |
| methyl4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate | C15H21NO3 | 1644667-61-7 | Details |
| 2-[2-(6-chloro-hexyloxy)-ethoxy]-ethylamine hydrochloride | C10H23Cl2NO2 | 1035373-85-3 | Details |
| 2,5-dimethyl-1,2,4-triazolo<1,5-a>-7(4H)-pyrimidone | C7H8N4O | 89852-99-3 | Details |
| 4-methylvaleraldehyde | C6H12O | 1119-16-0 | Details |
| 1-PYRIDIN-2-YL-1H-PYRAZOLE-3-CARBOXYLIC ACID | C9H7N3O2 | 1014631-58-3 | Details |
| 4-(aminomethyl)-2-bromobenzonitrile | C8H7BrN2 | 1177558-39-2 | Details |
| Drafloxacin Impurity 9 | Details |
| Octaethylene glycol | C16H34O9 | 5117-19-1 | Details |
| 2-Pyridinecarboxylicacid,1,6-dihydro-3-methyl-6-oxo-(9CI) | C7H7NO3 | 115185-81-4 | Details |
| 2-PIPERIDIN-4-YL-1H-BENZOIMIDAZOLE | C12H15N3 | 38385-95-4 | Details |
| Sobetirome | C20H24O4 | 211110-63-3 | Details |
| Drafloxacin Impurity 17 | Details |
| 4-bromo-4-methylpentanoic acid | C6H11BrO2 | 1379008-70-4 | Details |
| Piperazine, 1-[2-(4-pyridinyl)ethyl]- (9CI) | C11H17N3 | 53345-16-7 | Details |
| 3,5-Difluoropyridine-2,6-diamine | C5H5F2N3 | 247069-27-8 | Details |
| 2-phenylpentanedioic acid | C11H12O4 | 2628-87-7 | Details |
| (1-Bromo-2,2,2-trifluoroethyl)benzene | C8H6BrF3 | 434-42-4 | Details |
| Drafloxacin Impurity 5 | C18H12ClF3N4O4 | 2097714-11-7 | Details |
| 6-Methyl-2-benzothiazolecarboxylic acid | C9H7NO2S | 3507-18-4 | Details |
| methyl 3,5-bis(benzyloxy)-4-(3-{[(tert-butoxy)carbonyl]amino}prop-1-yn-1-yl)benzoate | Details |
| 5,5-DIMETHYL-DIHYDRO-FURAN-2-ONE | C6H10O2 | 3123-97-5 | Details |
| 7-bromo-1-methyl-1,3-dihydro-2H-benzimidazol-2-one | C8H7BrN2O | 913297-44-6 | Details |
| ethyl 4,7-dihydro-2-methyl-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate | C9H10N4O3 | 99179-11-0 | Details |
| Drafloxacin Impurity 6 | Details |
| ({N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycyl}amino)methyl acetate | C20H20N2O5 | 1599440-06-8 | Details |
| HO-PEG16-OH | C32H66O16 | 4669-05-0 | Details |
| 5-methyl-4-hexenoic acid | C7H12O2 | 5636-65-7 | Details |
| 6-bromobenzo[d]thiazole-2-carboxylic acid | C8H4BrNO2S | 1187928-32-0 | Details |
| 2-methyl-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diol | C6H6N4O2 | 1567029-19-9 | Details |
| DIETHYL 2,2-DIMETHYLGLUTARATE | C11H20O4 | 78092-07-6 | Details |
| 32-amino-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontanoic acid | Details |
| 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole | C16H23N3O | 110963-63-8 | Details |
| GSK1349572 | C20H19F2N3O5 | 1051375-16-6 | Details |
| Delafloxacin Impurity 1 | C17H12ClF3N4O3 | 2097714-10-6 | Details |
| 2-Methylglutaric acid | C6H10O4 | 18069-17-5 | Details |
| methyl 3,5-bis(benzyloxy)-4-iodobenzoate | Details |
| Drafloxacin Impurity 2 | Details |
| 2-(prop-2-yn-1-yl)pent-4-ynoic acid | C8H8O2 | 65994-70-9 | Details |
| 2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | C6H7N5 | 1435464-72-4 | Details |
| aminomethyl acetate | C3H7NO2 | 97423-53-5 | Details |
| 4-iodo-6-(trifluoromethyl)indoline-2,3-dione | C9H3F3INO2 | 389571-79-3 | Details |
| 1-(3-AMINOPROPYL)-4-METHYLPIPERAZINE | C8H19N3 | 4572-03-6 | Details |
| 4-AMino-7-broMoiMidazo[2,1-f][1,2,4]triazine | C5H4BrN5 | 1235374-44-3 | Details |
| Drafloxacin Impurity 4 | Details |
| Drafloxacin Impurity 14 | C18H14ClF3N4O5 | 208165-59-7 | Details |
| Cyclopropanepropanoic acid, 1-carboxy- | C7H10O4 | 33229-05-9 | Details |
| 4-methylpent-3-enoic acid | C6H10O2 | 504-85-8 | Details |
| Drafloxacin Impurity 16 | Details |
| Drafloxacin Impurity 10 | C29H17F6N3O6 | 906088-97-9 | Details |
| (1H-BENZO[D][1,2,3]TRIAZOL-5-YL)METHANOL | C7H7N3O | 106429-67-8 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||